Affiliation:
1. From the Center for Molecular Medicine and Department of Medicine, Karolinska Institutet, Stockholm, Sweden. A.-K.L.R.’s current address: Section of Immunobiology, Yale University School of Medicine, New Haven, Conn.
Abstract
Objective—
Atherosclerosis is associated with immune responses to oxidized low-density lipoprotein (oxLDL). The presence of activated macrophages and T cells in lesions suggests that cell-mediated immune reactions are taking place during the disease process. However, the role of specific immune responses has remained unclear. We have previously shown that transfer of CD4
+
T cells from apolipoprotein E knockout mice (apoE
−/−
) into immunodeficient apoE
−/−
scid/scid
mice accelerates disease.
Methods and Results—
To test whether this effect is dependent on specific disease-associated antigens, purified CD4
+
T cells from oxLDL-immunized mice were transferred into apoE
−/−
scid/scid
mice. CD4
+
T cells from mice immunized with a nonrelevant antigen, keyhole limpet hemocyanin (KLH), and naïve CD4
+
T cells were used as controls. After 12 weeks, all mice that received T cells had larger lesions than untouched apoE
−/−
scid/scid
controls. However, mice receiving CD4
+
T cells from oxLDL immunized mice had substantially accelerated lesion progression compared with those receiving naive or KLH-primed T cells. Circulating levels of interferon-γ were increased in proportion to the acceleration of atherosclerosis.
Conclusion—
These data show that adoptive transfer of purified CD4+ T cells from oxLDL-immunized mice accelerates atherosclerosis. They support the notion that Th1 cellular immunity is proatherogenic and identify oxLDL as a culprit autoantigen.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
129 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献